# Is Microdosing Actually Cheaper? We Checked All 556 Sellers

By Nora Bissett, Pricing Editor (https://glpwatchdog.org/authors/nora-bissett) | Published: 2026-08-15 | Updated: 2026-11-05

Canonical page: https://glpwatchdog.org/research/glp1-microdosing-price-check

> 31 sellers publish a microdose tier. The microdose is usually cheaper, but the two prices are quoted on different commitment terms, which is where the comparison breaks.

## Key points

- 31 of 556 sellers publish a microdose tier with a price; 9 publish one as their only standing compounded price.
- In 26 same-drug comparisons the microdose was cheaper in 23, median roughly two-thirds the standard price.
- The microdose is usually quoted month-to-month against a standard “as low as” twelve-month rate. That compares two contracts, not two doses.
- No FDA-approved label or completed trial establishes a microdose regimen; it is a commercial tier, not a clinical one.

Microdosing means taking a GLP-1 at less than the approved therapeutic dose (often a quarter to a half of a standard starting dose), usually for appetite control or maintenance rather than to reach a labeled target. It is now sold as its own product tier, and it is almost always advertised as the cheap way in. Whether it is cheaper turns out to depend less on the dose than on the commitment term each price is quoted on.

We checked on August 15, 2026. Of the 556 sellers in the register that day, 31 published a microdose tier with a price. In 26 cases we could compare that tier against the same seller's standard price *for the same drug*. The microdose was cheaper in 23 of them, at a median of about two-thirds the standard price. That seems like a clean answer. It is less clean than it looks, because the two prices are often quoted on different commitment terms.

## What a microdose actually is

There is no regulatory definition. No microdose regimen appears on an FDA-approved label, no trial has established one, and the doses sold under the name vary widely between sellers. In practice it means a dose below the lowest approved starting dose (below semaglutide's 0.25 mg or tirzepatide's 2.5 mg weekly), and it is a commercial category rather than a clinical one.[1][2] Some products sit right on that line: [Guppy Meds](https://glpwatchdog.org/reviews/guppy-meds) sells a semaglutide microdose of 0.25 mg and a tirzepatide microdose of 2.5 mg, the same numbers as the labeled starting doses.

> **That absence of evidence cuts in a specific direction.** The weight-loss results people have read about come from trials of the full titrated dose. A microdose is not a smaller version of that result; it is an untested regimen. It may suit someone maintaining a loss or intolerant of higher doses, and those are real reasons a clinician can weigh, but nobody can quote you a trial number for it, and a seller that does is quoting you somebody else's trial.

## Why the price comparison is rigged

At most sellers the “microdosing is cheaper” comparison is unreliable, because the two prices are usually quoted on **different commitment terms**. The microdose is shown as a month-to-month rate. The standard dose is shown as an “as low as” figure that requires a six- or twelve-month prepayment. Put side by side on a pricing page they look like two doses. They are two contracts.

[Telos Rx](https://glpwatchdog.org/reviews/telos-rx) is the clearest illustration in our data, and it is not an accusation: every figure below was published on its own site when we read it in August 2026. Its standard compounded tirzepatide is advertised “as low as $139 per month,” which is the twelve-month rate. Its microdosed injection is published as a tier ladder: $279 month-to-month, $234 at three months, $219 at six, $199 at twelve.

> **Disclosure.** GLP Watchdog earns a commission if you sign up with Telos Rx through a link on this site. The comparison below was worked out from its own published prices and is unchanged by that; we publish it because it is what the numbers show. Our full policy is at [/disclosure](https://glpwatchdog.org/disclosure).

*Telos Rx compounded tirzepatide: comparing like with like changes the answer*

| Comparison | Microdose | Standard | Result |
| --- | --- | --- | --- |
| Headline against headline | $279 (month-to-month) | $139 (“as low as”) | Microdose looks 2.0× the price |
| Matched at twelve months | $199 | $139 | Microdose is 1.4× the price |

Both rows are true and neither is the comparison a shopper makes on the page. That is the pattern: the term does more work than the dose. We hit the same thing at WeightCare. A $249 microdose looked more expensive than a $215 standard until we noticed the $215 is a six-month plan; the month-to-month standard is $399, and against that the microdose is far cheaper. [Idun Rx](https://glpwatchdog.org/reviews/idun-rx) shows how far the term alone can move one product: its semaglutide microdose program is $169 on a one-month plan and $79 a month on a 12-month plan. [bmiMD](https://glpwatchdog.org/reviews/bmimd)’s semaglutide microdose plan follows the same pattern: $129 on a one-month plan, or $99 a month on a 12-month plan paid up front as $1,188.

> **The one case that needs no correction.** At GOAL.MD, when we read it in August 2026, both compounded semaglutide prices were published with no term qualifier attached: the personalized all-doses plan is $179 a month and the Micro-Dose plan is $197. Same drug, same form, same terms, and the smaller dose costs $18 more. Telos Rx’s microdose also costs more once the terms are matched, but there the term had to be worked out first. Here it did not, and a like-for-like microdose price is rare.

[CoreAge Rx](https://glpwatchdog.org/reviews/coreage-rx) sells its semaglutide and tirzepatide microdosing programs at the same monthly price as its standard programs, so there a smaller dose does not bring a smaller bill. At [StackLab](https://glpwatchdog.org/reviews/stacklab), where each month-to-month plan renews every 28 days, either microdose injection is $129, $10 more than its standard semaglutide and $30 less than its standard tirzepatide. At [Josie](https://glpwatchdog.org/reviews/josie) either microdose injection is $189 a month on a month-to-month plan, against $249 a month for its standard semaglutide injection and $349 for tirzepatide, each billed monthly. Every seller with a published microdose price is on our boards for [microdose semaglutide](https://glpwatchdog.org/best/semaglutide-providers/microdose) and [microdose tirzepatide](https://glpwatchdog.org/best/tirzepatide-providers/microdose), each with the date we read it.

## How we nearly got this wrong

The same traps sit on the pricing pages you will read, so here is how we fell into them. Our first pass through the register produced a much louder headline, that four sellers charged more for the microdose than the standard dose. Every one of the four was an error in how we asked the question:

- One comparison was against **a seller’s own brand Wegovy listing at $1,695**. A compounded microdose is not expensive relative to a brand pen; they are different products.
- One seller matched only because its own record **says the microdose tier does not exist**. We had matched prose about microdosing rather than a microdose.
- One compared a **microdose of tirzepatide against a standard dose of semaglutide**. Within tirzepatide, that seller's microdose is cheaper.
- One compared a **month-to-month microdose against a six-month standard plan**.

Fixing the product, the drug and the record we matched removed three of the four. Matching the commitment term removed the fourth. We dropped the claim. The corrections are the useful part, because each one is a trap you can hit on a real pricing page.

## How to price a microdose properly

1. **Get both prices on the same term.** Ask what the microdose costs month-to-month and what the standard dose costs month-to-month. If the seller only quotes the standard dose as “as low as,” that is a twelve-month number and not the one you will pay in month one.
2. **Compare the same drug.** A microdose of tirzepatide and a standard dose of semaglutide are not alternatives to each other on price.
3. **Check the billing cadence, not the sentence.** One seller in our register advertised a $123 microdose in August 2026 that was actually billed $246 every other month. The monthly figure is honest arithmetic; it is just not a monthly charge.
4. **Ask what happens when you titrate up.** A microdose plan you outgrow is a plan you will be repriced on, and the price you are repriced to is the one that matters.
5. **Ask what dose, in milligrams.** “Microdose” is a marketing word, not a quantity. If nobody will put a number on it, you cannot compare it to anything. Our [units-to-milligrams guide](https://glpwatchdog.org/research/glp1-units-to-mg-conversion) helps here, because a small dose is where the syringe arithmetic gets error-prone.[3]

## Common questions

## Frequently asked questions

### What is a microdose of tirzepatide?

A dose below the 2.5 mg weekly starting dose on the approved label, commonly between about 0.5 mg and 1.5 mg. It varies by seller and no standard exists. It is a commercial tier, not a clinical category, and no FDA-approved label or completed trial establishes a microdose regimen.

### Is microdosing cheaper than a standard dose?

Usually, but by less than the pricing pages suggest. In our August 2026 count, across 26 same-drug comparisons, the microdose was cheaper in 23, at a median of roughly two-thirds the standard price. The catch is that the two prices are often quoted on different commitment terms, so a like-for-like gap is smaller than the headline gap.

### How many sellers offer microdosing?

When we counted on August 15, 2026, 31 of the 556 sellers in this register published a microdose tier with a price. Nine published a microdose as their only standing compounded price, which meant their headline figure was not reachable at a standard dose.

### Does microdosing work for weight loss?

Nobody can tell you from evidence, because the trials were run at full titrated doses. That does not mean it fails; it means the number a seller quotes you was measured on a different regimen. It is a question for a clinician who knows your history, not for a pricing page.

### Is a microdose safer, since it is less drug?

Lower doses generally produce fewer gastrointestinal side effects, which is a real reason some people use them. It does not follow that a microdose is a low-risk product: it is the same molecule, from the same compounding supply chain, with the same questions about who made it. Our guide to verifying an online pharmacy covers those.

Those questions also sort the sellers that offer a microdose today. Some make the comparison easy, some make it hard, and some do not let you make it before the intake. That last group is common: [about 30% of the sign-up funnels we have walked](https://glpwatchdog.org/research/what-519-signup-funnels-look-like) show no price until the questionnaire is done.

- [Avono Health](https://glpwatchdog.org/reviews/avono-health) and [NEUVÉ Health](https://glpwatchdog.org/reviews/neuve-health) post microdose and standard prices side by side before the intake. NEUVÉ prices by product and dose, and Avono says plainly that microdose results are less established than standard dosing. [BioPivot](https://glpwatchdog.org/reviews/biopivot) also posts both on its treatment pages, where the monthly semaglutide microdosing plan is $168 against $185 for its starter plan. [Astra](https://glpwatchdog.org/reviews/astra) lists both on its site as well: microdose semaglutide is $99 on its monthly plan, against $145 for the standard monthly plan, which costs the same at any dose.
- [Prescriva](https://glpwatchdog.org/reviews/prescriva) sells microdose plans next to month-to-month standard plans, and its longer 12-, 24- and 48-week options lower the monthly rate, so check which term a quoted figure belongs to. At [IonicMD](https://glpwatchdog.org/reviews/ionicmd) either microdose program is $179 per 4 weeks, against $249 for standard semaglutide and $279 for standard tirzepatide on the same month-to-month billing.
- [Nucore Health](https://glpwatchdog.org/reviews/nucore-health) asks for a three-month purchase to get its introductory microdose price, and the first-plan discount at [Medro](https://glpwatchdog.org/reviews/medro) drops away when the plan renews at the regular price. [AgelessRx](https://glpwatchdog.org/reviews/agelessrx) prices its semaglutide microdose at $99 a month on a four-month plan billed in full, then $159 a month after that. [Primma Wellness](https://glpwatchdog.org/reviews/primma-wellness) sells its semaglutide microdose as a one-time $199 order for one month or $349 paid up front for two months, with no subscription. [Enhanced](https://glpwatchdog.org/reviews/enhanced) has no month-to-month microdose plan: its advertised $59 semaglutide price means paying $708 for 12 months, and the shortest plan is three months at $79 a month.
- [Chronos Body Health & Wellness](https://glpwatchdog.org/reviews/chronos-bhw) sells compounded drugs as packages rather than monthly plans, which the clinic says last two and a half to three months at the starting dose. Divide before you compare.
- [Believe Health](https://glpwatchdog.org/reviews/believe-health) puts its microdose price on its peptide catalog page rather than its treatment pages, and [RX Bella](https://glpwatchdog.org/reviews/rx-bella) confirms the final price only after a provider reviews you.
- [Vea Health](https://glpwatchdog.org/reviews/vea-health) shows no price until you choose a plan and start the health intake, and [Wellspring Longevity Clinic](https://glpwatchdog.org/reviews/wellspring-longevity-clinic) posts a starting price without saying what billing period it covers.

## Sellers that publish a microdose price

You can see every seller's price rows, including any microdose tier and the term it is quoted on, in [the seller reviews](https://glpwatchdog.org/reviews). Prices in this register are recorded with the commitment term attached wherever the seller publishes one, because the term is where this comparison goes wrong. Our [breakdown of what drives compounded GLP-1 prices](https://glpwatchdog.org/research/what-drives-compounded-glp1-prices) covers the rest of the cost structure.

## References

1. U.S. National Library of Medicine WEGOVY (semaglutide) injection — prescribing information, including approved dosing schedule. DailyMed. 2026. https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=WEGOVY
2. U.S. National Library of Medicine ZEPBOUND (tirzepatide) injection — prescribing information, including approved dosing schedule. DailyMed. 2026. https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=ZEPBOUND
3. U.S. Food and Drug Administration FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. FDA Human Drug Compounding. 2024. https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-providers-compounders-and-patients-dosing-errors-associated-compounded

---

Cite as: GLP Watchdog, Nora Bissett, "Is Microdosing Actually Cheaper? We Checked All 556 Sellers", published 2026-08-15, updated 2026-11-05. https://glpwatchdog.org/research/glp1-microdosing-price-check

Canonical HTML page: https://glpwatchdog.org/research/glp1-microdosing-price-check

Medical disclaimer: Nothing here is medical advice. We report on this subject; we do not treat anyone. Whether to begin a medication, supplement, or treatment, whether to adjust it, and whether to stop are questions for a clinician licensed to answer them, who knows your history.